Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: Is the relevance of HLA-A locus matching being underestimated?

Transplant Immunology

Volumn 26, Issue 2-3, 2012, Pages 88-93

  Muro, Manuel ^a   López Álvarez, María R ^a   Campillo, Jose A ^a   Marin, Luis ^a   Moya Quiles, María R ^a   Bolarín, Jose M ^a   Botella, Carmen ^a   Salgado, Gema ^a   Martínez, Pedro ^a   Sánchez Bueno, Francisco ^a   López Hernández, Ruth ^a   Boix, Francisco ^a   Bosch, Alexandre ^a   Martínez, Helios ^a   De la Peña Moral, Jesús M ^a   Pérez, Noelia ^a   Robles, Ricardo ^a   García Alonso, Ana M ^a   Minguela, Alfredo ^a   Miras, Manuel ^a   Álvarez López, María R ^a   more..

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Graft survival; Liver transplant; Mismatching; Rejection

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ALCOHOL LIVER CIRRHOSIS; AMYLOIDOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HLA MATCHING; HLA TYPING; HUMAN; LIVER CANCER; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; WILSON DISEASE;

ADULT; FEMALE; GENETIC LOCI; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856528542     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.11.006     Document Type: Article

References (41)

1. Takemoto S., Terasaki P.I., Cecka J.M., Cho Y.W., Gjertson D.W. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. N Engl J Med 1992, 327:34.
2. Taylor C.J., Smith S.I., Sharples L.D., Parameshwar J., Cary N.R., Keogan M., et al. Human leukocyte antigen compatibility in heart transplantation. Transplantation 1997, 63:1346.
3. Adams D. Studies of human liver allograft rejection. Semin Liver Dis 1992, 12:180.
4. Markus B.H., Duquesnoy R.J., Gordon R.D., Fung J.J., Vanek M., Klintmalm G., et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?. Transplantation 1988, 46:372.
5. Donaldson P.T., Alexander G.J., OD́Grady J., Neuberger J., Portmann B., Thick M., et al. Evidence for an immune response to HLA class I antigens in the vanishing-bile duct syndrome after liver transplantation. Lancet 1987, I:945.
6. Nikaein A., Backman L., Jennings L., Levy M.F., Goldstein R., Gonwa T., et al. HLA compatibility and liver transplant outcome. Transplantation 1994, 58:786.
7. Balan V., Ruppert K., Demetris A.J., Ledneva T., Duquesnoy R.J., Detre K.M., et al. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology 2008, 48:878.
8. Jakab S.S., Navarro V.J., Colombe B.W., Daskalakis C., Herrine S.K., Rossi S. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database. Liver Transpl 2007, 13:1405.
9. Hashimoto T., Sugawara Y., Makuuchi M. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007, 13:938.
10. Langrehr J.M., Puhl G., Bahra M., Schmeding M., Spinelli A., Berg T., et al. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation. Liver Transpl 2006, 12:644.
11. Suehiro T., Shimada M., Kishikawa K., Shimura T., Soejima Y., Yoshizumi T., et al. Influence of HLA compatibility and lymphocyte crossmatching on acute cellular rejection following living donor adult liver transplantation. Liver Int 2005, 25:1182.
12. Castillo-Rama M., Castro M.J., Bernardo I., Meneu-Diaz J.C., Moreno Elola-Olaso A., Calleja-Antolin S.M., et al. Preformed Antibodies Detected by Cytotoxic Assay or Multibead Array Decrease Liver Allograft Survival: Role of Human Leukocyte Antigen Compatibility. Liver Transpl 2008, 14:554.
13. Lan X., Zhang M., Pu G., Guo C., Kang C., Li Y., et al. Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: A meta-analysis. World J Gastroenterol 2010, 16:3457.
14. Ontañón J., Muro M., García-Alonso A.M., Minguela A., Torio A., Bermejo J., et al. Effect of partial HLA-Class I match on acute rejection in viral preinfected human liver allograft recipients. Transplantation 1998, 65:1047.
15. Muro M., Álvarez-López M.R., Torío A., Ontañón J., Minguela A., Marín L., et al. HLA-DRB1 and -DQB1 polymorphism in liver recipients: relationship between HLA-DQB1*0302 allele frequency and acute rejection. Hum Immunol 1997, 56:70.
16. Gómez-Mateo J., Marin L., López-Alvarez M.R., Moya-Quiles M.R., Miras M., Marin-Moreno I., et al. TGF-beta1 gene polymorphism in liver graft recipients. Transpl Immunol 2006, 17:55.
17. Garcia-Alonso A.M., Minguela A., Muro M., Ontañón J., Torío A., Marin L., et al. CD28 expression on peripheral blood T lymphocytes after orthotopic liver transplant: Upregulation in acute rejection. Hum Immunol 1997, 53:64.
18. Moya-Quiles R., Muro M., Torío A., Sanchez-Bueno F., Miras M., Marin L., et al. Human Leukocyte Antigen-C in short- and long-term liver graft acceptance. Liver Transpl 2003, 9:218.
19. López-Alvarez R., Moya-Quiles R., Minguela A., Gil J., Miras M., Campillo J.Á., et al. HLA-C matching and liver transplants. Donor-recipient genotypes influence early outcome and CD8+KIR2D+ T cells recuperation. Transplantation 2009, 88:S54.
20. Moya-Quiles R., Alvarez R., Miras M., Gómez-Mateo J., López-Alvarez R., Marin-Moreno I., et al. Spanish Group of Transplant Immunology and Immunotolerance. Impact of recipient HLA-C in liver transplant: A protective effect of HLA-Cw*07 on acute rejection. Hum Immunol 2007, 68:51.
21. Muro M., Marin L., Miras M., Moya-Quiles M.R., Sánchez-Bueno F., Minguela A., et al. Human liver allograft recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor graft survival at the first year after transplantation. Experience of one centre. Transpl Immunol 2005, 14:91.
22. Muro M., Rojas G., Botella C., Miras M., Campillo J.A., Minguela A., et al. CT60A/G marker of the 3D́-UTR of CTLA-4 gene and liver transplant. Transpl Immunol 2008, 18:246.
23. Knechtle S.J., Kalayoglu M., D́Alessandro A.M., Mason B., Pirsch J.D., Sollinger H.W., et al. Histocompatibility and liver transplantation. Surgery 1993, 114:667.
24. Farges O., Saliba F., Farhamant H., Samuel D., Bismuth A., Reynes M., et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulin. Hepatology 1996, 23:240.
25. Donaldson P., Underhill J., Doherty D., Hayllar K., Calne R., Tan K.C., et al. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "The dualistic effect". Hepatology 1993, 17:1008.
26. Sugawara Y., Mizuta K., Kawarasaki H., Takayama T., Imamura H., Makuuchi M. Risk factors for acute rejection in paediatric living related liver transplantation: the impact of HLA matching. Liver Transpl 2001, 7:769.
27. Doran T.J., Geczy A.F., Painter D., McCaughan G., Sheil A.G., Susal C. A large, single centre investigation of the immunogenetic factors affecting liver transplantation. Transplantation 2000, 69:1232.
28. Evans P.C., Smith S., Hirschfield G., Rigapoulou E., Wreightt T.G., Wight D.G.D., et al. Recipient HLA-DR3, tumour necrosis factor-alpha promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are interrelated risk factors for chronic rejection of liver graft. J Hepatol 2001, 34:711.
29. Bathgate A.J., Hynd P., Sommerville D., Hayes P.C. The prediction of acute rejection in orthotopic liver transplantation. Liver Transpl Surg 1999, 5:475.
30. Wong T., Donaldson P., Devlin J., Willians R. Repeat HLA-B and -DR loci mismatching at second liver transplantation improves patient survival. Transplantation 1996, 61:440.
31. Mañez R., Mateo R., Tabasco J., Kusne S., Starzl T.E., Duquesnoy R.J. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995, 59:640.
32. Paya C.V., Wiesner R.H., Hermans P.E., Larson-Keller J.J., Ilstrup D.M., Krom R.A., et al. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology 1992, 23:1666.
33. Yamamoto E., Honda K., Tanaka K., Awane M., Takeda R., Fukushin S., et al. Evaluating the significance of HLA class II genotype matching in living-related liver transplantation. Transpl Immunol 1996, 4:144.
34. Thorogood J. Relationship between HLA compatibility and first liver allograft survival. Transplant Proc 1993, 25:2655.
35. Meyer C., Parrisiadis A., Compagnon P., Nisand G., Woehl-Jaegle M.L., Ellero B., et al. Effect of HLA compatibility in liver transplantation: Is a predictive factor of postoperative outcome. Transplant Proc 1997, 29:2332.
36. Dawson S., Imagawa D.K., Johnson C., Cecka M., Terasaki P.I., Shackleton C.R., et al. UCLA liver transplantation: analysis of immunological factors affecting outcome. Artif Organs 1996, 20:1063.
37. Poli F., Nocco A., Crespiatico L., Cattaneo R., Lecchi L., Scalamogna M., et al. A retrospective evaluation of HLA-A, B and genomic HLA-DR compatibility in orthotopic liver transplantation. Transpl Proc 1994, 26:3614.
38. Vargas H.E., Laskus T., Wang L.F., Radkowski M., Poutous A., Lee R., et al. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg 1998, 4:22.
39. Poli F., Scalamogna M., Aniasi A., Brambilla C., Cardillo M., Crespiatico L., et al. A retrospective evaluation of HLA-A, B and -DRB1 matching on liver transplantation. Transplant Int 1998, 11(S1):S347.
40. Poli F., Frison S., Cardillo M., Scalamogna M., Longhi E., Crespiatico L., et al. A retrospective analysis of HLA matching and other factors on liver graft outcome. Transplant Proc 2001, 33:1368.
41. Sibley R.K., Sutherland D.E.R., Goetz F., Michael A.F. Recurrent diabetes mellitus in pancreas iso- and allograft. Lab Invest 1985, 53:132.